LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Migraine Therapies Alder specializes in developing monoclonal antibody treatments for migraine prevention, with ongoing projects like ALD1910 and eptinezumab, offering opportunities to collaborate or provide complementary products for migraine management.

Recent Market Entry The company has recently launched eptinezumab in the U.S. and is actively engaging with payers, indicating a readiness to expand distribution channels and commercial partnerships within the migraine treatment space.

Strong Funding & Growth With substantial funding of $170 million and a recent IPO, Alder is positioned for rapid growth, presenting opportunities for financial partnerships, joint ventures, and investments in innovative biotech solutions.

Customer-Centric Focus Alder’s deep understanding of migraine patient needs and its commitment to better therapies create opportunities to develop patient engagement platforms, support programs, or ancillary services to enhance treatment adherence and patient outcomes.

Similar companies to Alder Biopharmaceuticals

Alder Biopharmaceuticals Tech Stack

Alder Biopharmaceuticals uses 8 technology products and services including SiteCatalyst, Drupal, WordPress, and more. Explore Alder Biopharmaceuticals's tech stack below.

  • SiteCatalyst
    Analytics
  • Drupal
    Content Management System
  • WordPress
    Content Management System
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Adobe Creative Suite
    Visualisation Software

Media & News

Alder Biopharmaceuticals's Email Address Formats

Alder Biopharmaceuticals uses at least 1 format(s):
Alder Biopharmaceuticals Email FormatsExamplePercentage
FLast@alderbio.comJDoe@alderbio.com
43%
Last@alderbio.comDoe@alderbio.com
7%
FLast@alderbio.comJDoe@alderbio.com
43%
Last@alderbio.comDoe@alderbio.com
7%

Frequently Asked Questions

Where is Alder Biopharmaceuticals's headquarters located?

Minus sign iconPlus sign iconAlder Biopharmaceuticals's main headquarters is located at 11804 N Creek Pkwy S Bothell, WA 98011 US. The company has employees across 1 continents, including North America.

What is Alder Biopharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Alder Biopharmaceuticals's main corporate office by phone at
+1-425-205-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alder Biopharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconAlder Biopharmaceuticals's official website is alderbio.com and has social profiles on LinkedIn.

How much revenue does Alder Biopharmaceuticals generate?

Minus sign iconPlus sign icon As of October 2025, Alder Biopharmaceuticals's annual revenue is estimated to be $55M.

What is Alder Biopharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconAlder Biopharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alder Biopharmaceuticals have currently?

Minus sign iconPlus sign iconAs of October 2025, Alder Biopharmaceuticals has approximately 51 employees across 1 continents, including North America. Key team members include Chief Commercial Officer: E. S.Chief Business Officer: M. L.Executive Assistant To Chief Executive Officer: P. S.. Explore Alder Biopharmaceuticals's employee directory with LeadIQ.

What industry does Alder Biopharmaceuticals belong to?

Minus sign iconPlus sign iconAlder Biopharmaceuticals operates in the Biotechnology Research industry.

What technology does Alder Biopharmaceuticals use?

Minus sign iconPlus sign iconAlder Biopharmaceuticals's tech stack includes SiteCatalystDrupalWordPressGoogle Fonts APIjQueryUnderscore.jsBootstrapAdobe Creative Suite.

What is Alder Biopharmaceuticals's email format?

Minus sign iconPlus sign iconAlder Biopharmaceuticals's email format typically follows the pattern of FLast@alderbio.com. Find more Alder Biopharmaceuticals email formats with LeadIQ.

How much funding has Alder Biopharmaceuticals raised to date?

Minus sign iconPlus sign icon As of October 2025, Alder Biopharmaceuticals has raised $170M in funding. The last funding round occurred on Apr 10, 2019 for $170M.

When was Alder Biopharmaceuticals founded?

Minus sign iconPlus sign iconAlder Biopharmaceuticals was founded in 2004.

Alder Biopharmaceuticals

Biotechnology ResearchWashington, United States51-200 Employees

Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialization of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back.
 
Alder knows the physical and emotional toll migraine can take not just on the individual but also those who care for them. In fact, some of our employees suffer from migraine themselves. To Alder, people with migraine are not “nameless” subjects or data points, but friends, family, and others whose stories motivate Alder to do its best work. The team’s insight into the needs of migraine patients has enabled us to leverage our monoclonal antibody expertise to design best-in-class therapies.

Section iconCompany Overview

Headquarters
11804 N Creek Pkwy S Bothell, WA 98011 US
Phone number
+1-425-205-****
Website
alderbio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2004
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $170M

    Alder Biopharmaceuticals has raised a total of $170M of funding over 6 rounds. Their latest funding round was raised on Apr 10, 2019 in the amount of $170M.

  • $10M$25M

    Alder Biopharmaceuticals's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $170M

    Alder Biopharmaceuticals has raised a total of $170M of funding over 6 rounds. Their latest funding round was raised on Apr 10, 2019 in the amount of $170M.

  • $10M$25M

    Alder Biopharmaceuticals's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    E. S.
    Chief Commercial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. S.
    Executive Assistant To Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Fire Chief
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. B.
    Vice President
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. H.
    Department Head Abs Technology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. C.
    Senior Director, Human Resources
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. Q.
    Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Y. Z.
    Director Of Biostatistics, Biometrics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. M.
    Senior Manager Recruiting
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.